{"id":"https://openalex.org/W2884696648","doi":"https://doi.org/10.1093/annonc/mdy241","title":"Nintedanib for the treatment of patients with refractory metastatic colorectal cancer (LUME-Colon 1): a phase III, international, randomized, placebo-controlled study","display_name":"Nintedanib for the treatment of patients with refractory metastatic colorectal cancer (LUME-Colon 1): a phase III, international, randomized, placebo-controlled study","alternate_titles":[],"publication_year":2018,"publication_date":"2018-07-13","ids":{"openalex":"https://openalex.org/W2884696648","doi":"https://doi.org/10.1093/annonc/mdy241","mag":"2884696648","pmid":"https://pubmed.ncbi.nlm.nih.gov/30010751","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6158765"},"language":"en","primary_location":{"id":"doi:10.1093/annonc/mdy241","doi":"https://doi.org/10.1093/annonc/mdy241","is_oa":true,"landing_page_url":"https://doi.org/10.1093/annonc/mdy241","pdf_url":"https://academic.oup.com/annonc/article-pdf/29/9/1955/26414215/mdy241.pdf","source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2884696648"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://academic.oup.com/annonc/article-pdf/29/9/1955/26414215/mdy241.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090645179","display_name":"Eric Van Cutsem","orcid":"https://orcid.org/0000-0002-6372-1230","observed_orcids":["https://orcid.org/0000-0002-6372-1230"]},"institutions":[{"id":"https://openalex.org/I2800231306","display_name":"Universitair Ziekenhuis Leuven","ror":"https://ror.org/0424bsv16","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I2800231306"]},{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"E. Van Cutsem","raw_affiliation_strings":["Division of Digestive Oncology, University Hospitals Gasthuisberg Leuven and KU Leuven, Leuven, Belgium. Electronic address: eric.vancutsem@uzleuven.be","Division of Digestive Oncology, University Hospitals Gasthuisberg Leuven and KU Leuven, Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Digestive Oncology, University Hospitals Gasthuisberg Leuven and KU Leuven, Leuven, Belgium. Electronic address: eric.vancutsem@uzleuven.be","institution_ids":["https://openalex.org/I2800231306","https://openalex.org/I99464096"]},{"raw_affiliation_string":"Division of Digestive Oncology, University Hospitals Gasthuisberg Leuven and KU Leuven, Leuven, Belgium","institution_ids":["https://openalex.org/I2800231306","https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062748030","display_name":"Takayuki Yoshino","orcid":"https://orcid.org/0000-0002-0489-4756","observed_orcids":["https://orcid.org/0000-0002-0489-4756"]},"institutions":[{"id":"https://openalex.org/I4210145079","display_name":"National Cancer Center Hospital East","ror":"https://ror.org/03rm3gk43","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210145079"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"T. Yoshino","raw_affiliation_strings":["Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, Japan","institution_ids":["https://openalex.org/I4210145079"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045441776","display_name":"Heinz\u2010Josef Lenz","orcid":"https://orcid.org/0000-0003-2178-9568","observed_orcids":["https://orcid.org/0000-0003-2178-9568"]},"institutions":[{"id":"https://openalex.org/I4210117038","display_name":"USC Norris Comprehensive Cancer Center","ror":"https://ror.org/01nmyfr60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800154431","https://openalex.org/I4210117038"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"H.J. Lenz","raw_affiliation_strings":["Division of Medical Oncology, Norris Comprehensive Cancer Center, Los Angeles, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology, Norris Comprehensive Cancer Center, Los Angeles, USA","institution_ids":["https://openalex.org/I4210117038"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051613962","display_name":"Sara Lonardi","orcid":"https://orcid.org/0000-0002-7593-8138","observed_orcids":["https://orcid.org/0000-0002-7593-8138"]},"institutions":[{"id":"https://openalex.org/I4210109345","display_name":"Istituto Oncologico Veneto","ror":"https://ror.org/01xcjmy57","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210109345","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S. Lonardi","raw_affiliation_strings":["Medical Oncology Unit 1, Department of Clinical and Experimental Oncology, Istituto Oncologico Veneto - IRCCS, Padua"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Unit 1, Department of Clinical and Experimental Oncology, Istituto Oncologico Veneto - IRCCS, Padua","institution_ids":["https://openalex.org/I4210109345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012034272","display_name":"Alfredo Falcone","orcid":"https://orcid.org/0000-0001-5840-2529","observed_orcids":["https://orcid.org/0000-0001-5840-2529"]},"institutions":[{"id":"https://openalex.org/I108290504","display_name":"University of Pisa","ror":"https://ror.org/03ad39j10","country_code":"IT","type":"education","lineage":["https://openalex.org/I108290504"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A. Falcone","raw_affiliation_strings":["Department of Translational Research on New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Translational Research on New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy","institution_ids":["https://openalex.org/I108290504"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031976935","display_name":"Mar\u00eda Luisa Lim\u00f3n","orcid":"https://orcid.org/0000-0003-4409-3029","observed_orcids":["https://orcid.org/0000-0003-4409-3029"]},"institutions":[{"id":"https://openalex.org/I4210153139","display_name":"Hospital Universitario Virgen del Roc\u00edo","ror":"https://ror.org/04vfhnm78","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210153139"]}],"countries":["ES"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M.L. Lim\u00f3n","raw_affiliation_strings":["Department of Medical Oncology, Hospital Universitario Virgen del Rocio, Seville, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Hospital Universitario Virgen del Rocio, Seville, Spain","institution_ids":["https://openalex.org/I4210153139"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040081800","display_name":"Mark P. Saunders","orcid":"https://orcid.org/0000-0002-7195-4712","observed_orcids":["https://orcid.org/0000-0002-7195-4712"]},"institutions":[{"id":"https://openalex.org/I4210131968","display_name":"The Christie Hospital","ror":"https://ror.org/03nd63441","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]},{"id":"https://openalex.org/I4210133995","display_name":"The Christie NHS Foundation Trust","ror":"https://ror.org/03v9efr22","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210133995"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M. Saunders","raw_affiliation_strings":["Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK","institution_ids":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011308487","display_name":"Alberto Felice Sobrero","orcid":"https://orcid.org/0000-0001-7764-673X","observed_orcids":["https://orcid.org/0000-0001-7764-673X"]},"institutions":[{"id":"https://openalex.org/I4210146472","display_name":"Ospedale Policlinico San Martino","ror":"https://ror.org/04d7es448","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210146472","https://openalex.org/I4210153126","https://openalex.org/I4405264730"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A. Sobrero","raw_affiliation_strings":["Department of Medical Oncology, Azienda Ospedaliera San Martino, Genoa, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Azienda Ospedaliera San Martino, Genoa, Italy","institution_ids":["https://openalex.org/I4210146472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084099617","display_name":"Y.S. Park","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802194831","display_name":"Samsung Medical Center","ror":"https://ror.org/05a15z872","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I2250650973","https://openalex.org/I2802194831"]}],"countries":["KR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Y.S. Park","raw_affiliation_strings":["Department of Hematology and Oncology, Samsung Medical Center, Seoul, South Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Oncology, Samsung Medical Center, Seoul, South Korea","institution_ids":["https://openalex.org/I2802194831"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072908623","display_name":"Reyes Ferreiro","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210161852","display_name":"Hospital Universitario Ram\u00f3n y Cajal","ror":"https://ror.org/050eq1942","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210139293","https://openalex.org/I4210161852"]}],"countries":["ES"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"R. Ferreiro","raw_affiliation_strings":["Department of Clinical Oncology, Ram\u00f3n y Cajal Hospital, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Oncology, Ram\u00f3n y Cajal Hospital, Madrid, Spain","institution_ids":["https://openalex.org/I4210161852"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017195273","display_name":"Yong Sang Hong","orcid":"https://orcid.org/0000-0001-5672-0072","observed_orcids":["https://orcid.org/0000-0001-5672-0072"]},"institutions":[{"id":"https://openalex.org/I2801680663","display_name":"Asan Medical Center","ror":"https://ror.org/03s5q0090","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I2801680663","https://openalex.org/I4210167194"]}],"countries":["KR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Y.S. Hong","raw_affiliation_strings":["Department of Oncology, Asan Medical Center, Seoul, South Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Asan Medical Center, Seoul, South Korea","institution_ids":["https://openalex.org/I2801680663"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025634287","display_name":"Ji\u0159\u00ed Tom\u00e1\u0161ek","orcid":"https://orcid.org/0000-0002-7635-9103","observed_orcids":["https://orcid.org/0000-0002-7635-9103"]},"institutions":[{"id":"https://openalex.org/I4210115043","display_name":"Masaryk Memorial Cancer Institute","ror":"https://ror.org/0270ceh40","country_code":"CZ","type":"facility","lineage":["https://openalex.org/I4210115043"]}],"countries":["CZ"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J. Tomasek","raw_affiliation_strings":["Department of Complex Oncology Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Complex Oncology Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic","institution_ids":["https://openalex.org/I4210115043"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101879422","display_name":"Hiroya Taniguchi","orcid":"https://orcid.org/0000-0002-4684-9734","observed_orcids":["https://orcid.org/0000-0002-4684-9734"]},"institutions":[{"id":"https://openalex.org/I4210133851","display_name":"Aichi Cancer Center","ror":"https://ror.org/03kfmm080","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210133851"]},{"id":"https://openalex.org/I4405286927","display_name":"Aichi Cancer Center Hospital","ror":"https://ror.org/03kh0z432","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210133851","https://openalex.org/I4405286927"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"H. Taniguchi","raw_affiliation_strings":["Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan","institution_ids":["https://openalex.org/I4210133851","https://openalex.org/I4405286927"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056034569","display_name":"Fortunato Ciardiello","orcid":"https://orcid.org/0000-0002-3369-4841","observed_orcids":["https://orcid.org/0000-0002-3369-4841"]},"institutions":[{"id":"https://openalex.org/I197809005","display_name":"University of Campania \"Luigi Vanvitelli\"","ror":"https://ror.org/02kqnpp86","country_code":"IT","type":"education","lineage":["https://openalex.org/I197809005"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"F. Ciardiello","raw_affiliation_strings":["Oncologia Medica, Seconda Universit\u00e0 deli Studi di Napoli, Naples, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncologia Medica, Seconda Universit\u00e0 deli Studi di Napoli, Naples, Italy","institution_ids":["https://openalex.org/I197809005"]}]},{"author_position":"middle","author":{"id":null,"display_name":"J. Stoehr","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J. Stoehr","raw_affiliation_strings":["Boehringer Ingelheim, Pharma GmbH & Co. KG, Biberach, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim, Pharma GmbH & Co. KG, Biberach, Germany","institution_ids":["https://openalex.org/I1330995197"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060433264","display_name":"Zohra Oum'Hamed","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210139229","display_name":"Boehringer Ingelheim (France)","ror":"https://ror.org/03gdpyq31","country_code":"FR","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210139229"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Z. Oum\u2019Hamed","raw_affiliation_strings":["Boehringer Ingelheim France S.A.S, Reims, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim France S.A.S, Reims, France","institution_ids":["https://openalex.org/I4210139229"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013909542","display_name":"Soetkin Vlassak","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210128954","display_name":"Boehringer Ingelheim (Belgium)","ror":"https://ror.org/0324red69","country_code":"BE","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210128954"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S. Vlassak","raw_affiliation_strings":["SCS Boehringer Ingelheim Comm.V, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"SCS Boehringer Ingelheim Comm.V, Brussels, Belgium","institution_ids":["https://openalex.org/I4210128954"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057106249","display_name":"Matus Studeny","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210119669","display_name":"Boehringer Ingelheim (Austria)","ror":"https://ror.org/026vtvm28","country_code":"AT","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210119669"]}],"countries":["AT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M. Studeny","raw_affiliation_strings":["Division of Medicine/Clinical Development Department, Boehringer Ingelheim, Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medicine/Clinical Development Department, Boehringer Ingelheim, Vienna, Austria","institution_ids":["https://openalex.org/I4210119669"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5053880366","display_name":"Guillem Argil\u00e9s","orcid":"https://orcid.org/0000-0002-1487-7108","observed_orcids":["https://orcid.org/0000-0002-1487-7108"]},"institutions":[{"id":"https://openalex.org/I123044942","display_name":"Universitat Aut\u00f2noma de Barcelona","ror":"https://ror.org/052g8jq94","country_code":"ES","type":"education","lineage":["https://openalex.org/I123044942"]},{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]},{"id":"https://openalex.org/I4210158561","display_name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer","ror":"https://ror.org/04hya7017","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210158561"]},{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"G. Argiles","raw_affiliation_strings":["Medical Oncology Department, Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Universitat Aut\u00f2noma de Barcelona, CIBERONC, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Department, Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Universitat Aut\u00f2noma de Barcelona, CIBERONC, Barcelona, Spain","institution_ids":["https://openalex.org/I123044942","https://openalex.org/I4210127641","https://openalex.org/I4210158561","https://openalex.org/I4387155398"]}]}],"institutions":[],"countries_distinct_count":11,"institutions_distinct_count":25,"corresponding_author_ids":["https://openalex.org/A5090645179"],"corresponding_institution_ids":["https://openalex.org/I2800231306","https://openalex.org/I99464096"],"apc_list":{"value":5080,"currency":"USD","value_usd":5080},"apc_paid":{"value":5080,"currency":"USD","value_usd":5080},"fwci":3.0639,"has_fulltext":true,"cited_by_count":70,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.94294446,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"29","issue":"9","first_page":"1955","last_page":"1963"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10335","display_name":"Colorectal Cancer Surgical Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nintedanib","display_name":"nintedanib","score":1.0},{"id":"https://openalex.org/keywords/metastatic-colorectal-cancer","display_name":"metastatic colorectal cancer","score":0.9919999837875366},{"id":"https://openalex.org/keywords/refractory-colorectal-cancer","display_name":"refractory colorectal cancer","score":0.8960000276565552},{"id":"https://openalex.org/keywords/angiogenesis-inhibitors","display_name":"angiogenesis inhibitors","score":0.7630000114440918},{"id":"https://openalex.org/keywords/angiokinase-inhibitors","display_name":"angiokinase inhibitors","score":0.7429999709129333},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.7829999923706055},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":1.0},{"id":"https://openalex.org/keywords/liver-related-adverse-events","display_name":"liver-related adverse events","score":0.7120000123977661},{"id":"https://openalex.org/keywords/fatigue","display_name":"fatigue","score":0.5410000085830688},{"id":"https://openalex.org/keywords/regorafenib","display_name":"regorafenib","score":0.6830000281333923},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.4300000071525574},{"id":"https://openalex.org/keywords/drug-efficacy-and-safety","display_name":"drug safety and efficacy","score":0.5230000019073486},{"id":"https://openalex.org/keywords/locally-advanced-colorectal-cancer","display_name":"locally advanced colorectal cancer","score":0.6819999814033508},{"id":"https://openalex.org/keywords/objective-response","display_name":"objective response","score":0.6150000095367432},{"id":"https://openalex.org/keywords/disease-control-rate","display_name":"disease control rate","score":0.6389999985694885}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.925479531288147},{"id":"https://openalex.org/C2780171596","wikidata":"https://www.wikidata.org/wiki/Q15149723","display_name":"Nintedanib","level":4,"score":0.8680095672607422},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6980286240577698},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.6568194627761841},{"id":"https://openalex.org/C2776248978","wikidata":"https://www.wikidata.org/wiki/Q3891664","display_name":"Regorafenib","level":4,"score":0.6157584190368652},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6065244078636169},{"id":"https://openalex.org/C119060515","wikidata":"https://www.wikidata.org/wiki/Q1916617","display_name":"Interquartile range","level":2,"score":0.5579570531845093},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.5248779654502869},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.470805287361145},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4572429955005646},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4220949411392212},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.41933003067970276},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4128350615501404},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.347698450088501},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2639976143836975},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.2272830307483673},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.11047807335853577},{"id":"https://openalex.org/C2778341716","wikidata":"https://www.wikidata.org/wiki/Q2290446","display_name":"Idiopathic pulmonary fibrosis","level":3,"score":0.0},{"id":"https://openalex.org/C2777714996","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung","level":2,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000077982","descriptor_name":"Progression-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005221","descriptor_name":"Fatigue","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D005221","descriptor_name":"Fatigue","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010919","descriptor_name":"Placebos","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010919","descriptor_name":"Placebos","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D015179","descriptor_name":"Colorectal Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D040262","descriptor_name":"Receptors, Vascular Endothelial Growth Factor","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D056486","descriptor_name":"Chemical and Drug Induced Liver Injury","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D056486","descriptor_name":"Chemical and Drug Induced Liver Injury","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D066066","descriptor_name":"Response Evaluation Criteria in Solid Tumors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":12,"locations":[{"id":"doi:10.1093/annonc/mdy241","doi":"https://doi.org/10.1093/annonc/mdy241","is_oa":true,"landing_page_url":"https://doi.org/10.1093/annonc/mdy241","pdf_url":"https://academic.oup.com/annonc/article-pdf/29/9/1955/26414215/mdy241.pdf","source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},{"id":"pmh:oai:lirias2repo.kuleuven.be:123456789/637232","doi":null,"is_oa":true,"landing_page_url":"https://lirias.kuleuven.be/handle/123456789/637232","pdf_url":"https://lirias.kuleuven.be/retrieve/1092b2af-4906-448e-8120-4cc51826a6f6","source":{"id":"https://openalex.org/S4306401954","display_name":"Lirias (KU Leuven)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I99464096","host_organization_name":"KU Leuven","host_organization_lineage":["https://openalex.org/I99464096"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals Of Oncology, vol. 29 (9), (1955-1963)","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:europepmc.org:5114648","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC6158765","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:6158765","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6158765/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ann Oncol","raw_type":"Text"},{"id":"pmid:30010751","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30010751","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of oncology : official journal of the European Society for Medical Oncology","raw_type":"Clinical Trial, Phase III"},{"id":"pmh:oai:www.repositoriosalud.es:10668/12712","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6158765/pdf","pdf_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6158765/pdf","source":{"id":"https://openalex.org/S4377196114","display_name":"RISalud Institutional Health Repository of Andaluc\u00eda","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"research article"},{"id":"pmh:oai:ddd.uab.cat:227950","doi":null,"is_oa":true,"landing_page_url":"https://ddd.uab.cat/record/227950","pdf_url":"https://ddd.uab.cat/pub/artpub/2018/pmc_30010751/pmc_30010751.pdf","source":{"id":"https://openalex.org/S4306400380","display_name":"Dip\u00f2sit Digital de Documents de la UAB (Universitat Aut\u00f2noma de Barcelona)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I123044942","host_organization_name":"Universitat Aut\u00f2noma de Barcelona","host_organization_lineage":["https://openalex.org/I123044942"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"},{"id":"pmh:oai:arpi.unipi.it:11568/940960","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11568/940960","pdf_url":null,"source":{"id":"https://openalex.org/S4377196265","display_name":"CINECA IRIS Institutial research information system (University of Pisa)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I108290504","host_organization_name":"University of Pisa","host_organization_lineage":["https://openalex.org/I108290504"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:dnet:ricscm______::6bbabeba2bdba3a605775dbe3c9787f1","doi":null,"is_oa":true,"landing_page_url":"https://repositoriosaludmadrid.es/handle/20.500.12530/36062","pdf_url":null,"source":{"id":"https://openalex.org/S4306402641","display_name":"LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Cient\u00edficas)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4383465926","host_organization_name":"LA Referencia","host_organization_lineage":["https://openalex.org/I4383465926"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:dnet:uabarcelona_::41c64729dad6c288d79aa1336e5a77d3","doi":null,"is_oa":true,"landing_page_url":"http://ddd.uab.cat/record/227950","pdf_url":null,"source":{"id":"https://openalex.org/S4306402641","display_name":"LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Cient\u00edficas)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4383465926","host_organization_name":"LA Referencia","host_organization_lineage":["https://openalex.org/I4383465926"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:iris.unicampania.it:11591/400962","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11591/400962","pdf_url":null,"source":{"id":"https://openalex.org/S7407055255","display_name":"Archivio Istituzionale della Ricerca - Universit\u00e0 degli Studi della Campania \"Luigi Vanvitelli\"","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:recercat.cat:2072/441380","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/2072/441380","pdf_url":null,"source":{"id":"https://openalex.org/S4306402147","display_name":"RECERCAT (Consorci de Serveis Universitaris de Catalunya)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210090028","host_organization_name":"Consorci de Serveis Universitaris de Catalunya","host_organization_lineage":["https://openalex.org/I4210090028"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"}],"best_oa_location":{"id":"doi:10.1093/annonc/mdy241","doi":"https://doi.org/10.1093/annonc/mdy241","is_oa":true,"landing_page_url":"https://doi.org/10.1093/annonc/mdy241","pdf_url":"https://academic.oup.com/annonc/article-pdf/29/9/1955/26414215/mdy241.pdf","source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320306257","display_name":"Boehringer Ingelheim","ror":"https://ror.org/05kffp613"},{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"},{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"},{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320309086","display_name":"Celgene","ror":"https://ror.org/0527yg379"},{"id":"https://openalex.org/F4320311647","display_name":"Merck KGaA","ror":"https://ror.org/04b2dty93"},{"id":"https://openalex.org/F4320311653","display_name":"Taiho Pharmaceutical","ror":"https://ror.org/02v50dx14"},{"id":"https://openalex.org/F4320315887","display_name":"GlaxoSmithKline Japan","ror":"https://ror.org/01j6sxy67"},{"id":"https://openalex.org/F4320327235","display_name":"Servier","ror":"https://ror.org/034e7c066"},{"id":"https://openalex.org/F4320327436","display_name":"Yakult Honsha","ror":"https://ror.org/03wmnrc91"},{"id":"https://openalex.org/F4320328293","display_name":"Boehringer Ingelheim France","ror":"https://ror.org/03gdpyq31"},{"id":"https://openalex.org/F4320328455","display_name":"Ipsen","ror":"https://ror.org/00d801g55"},{"id":"https://openalex.org/F4320333003","display_name":"Chugai Pharmaceutical","ror":"https://ror.org/01vepzj85"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2884696648.pdf","grobid_xml":"https://content.openalex.org/works/W2884696648.grobid-xml"},"referenced_works_count":16,"referenced_works":["https://openalex.org/W242040007","https://openalex.org/W1952983316","https://openalex.org/W1991939191","https://openalex.org/W1999130958","https://openalex.org/W2002064506","https://openalex.org/W2089756110","https://openalex.org/W2144330816","https://openalex.org/W2147834058","https://openalex.org/W2195700916","https://openalex.org/W2197641370","https://openalex.org/W2200887263","https://openalex.org/W2238285053","https://openalex.org/W2470575266","https://openalex.org/W2528885621","https://openalex.org/W4238105128","https://openalex.org/W4238604577"],"related_works":["https://openalex.org/W2564425438","https://openalex.org/W2587295933","https://openalex.org/W1952983316","https://openalex.org/W2340150156","https://openalex.org/W4245659308","https://openalex.org/W2761248196","https://openalex.org/W3087421415","https://openalex.org/W2913166029","https://openalex.org/W2602281547","https://openalex.org/W2197641370"],"abstract_inverted_index":{"Background:":[0],"Angiogenesis":[1],"is":[2],"critical":[3],"to":[4,72,81,110,145,272],"colorectal":[5],"cancer":[6],"(CRC)":[7],"growth":[8],"and":[9,38,53,112,121,135,243,262,283],"metastasis.":[10],"Phase":[11],"I/II":[12],"studies":[13],"have":[14],"demonstrated":[15],"the":[16,36],"efficacy":[17,37],"of":[18,40,49,107,239,245],"nintedanib,":[19],"a":[20,200,287],"triple":[21],"angiokinase":[22],"inhibitor,":[23],"in":[24,42,205,237,292],"patients":[25,43,56,149,242],"with":[26,44,64,179,184,207,286],"metastatic":[27,108],"CRC.":[28],"This":[29],"global,":[30],"randomized,":[31],"phase":[32],"III":[33],"study":[34,270],"investigated":[35],"safety":[39],"nintedanib":[41,83,180,208],"refractory":[45],"CRC":[46,69],"after":[47],"failure":[48],"standard":[50],"therapies.":[51],"Patients":[52,98],"methods:":[54],"Eligible":[55],"(Eastern":[57],"Cooperative":[58],"Oncology":[59],"Group":[60],"performance":[61],"status":[62],"0-1,":[63],"histologically/cytologically":[65],"confirmed":[66],"metastatic/locally":[67],"advanced":[68],"adenocarcinoma":[70],"unamenable":[71],"surgery":[73],"and/or":[74],"radiotherapy)":[75],"were":[76,99,117,150,153,227,255],"randomized":[77],"1":[78,80],":":[79],"receive":[82],"(200":[84],"mg":[85],"twice":[86],"daily)":[87],"or":[88,95,230],"placebo":[89,159,210,260,266],"(twice":[90],"daily),":[91],"until":[92],"disease":[93,109,136],"progression":[94],"undue":[96],"toxicity.":[97],"stratified":[100],"by":[101,125,138],"previous":[102],"regorafenib,":[103],"time":[104],"from":[105],"onset":[106],"randomization,":[111],"region.":[113],"Co-primary":[114],"end":[115,129,276],"points":[116,130],"overall":[118],"survival":[119,123],"(OS)":[120],"progression-free":[122],"(PFS)":[124],"central":[126,139],"review.":[127,140],"Secondary":[128],"included":[131],"objective":[132],"tumor":[133],"response":[134],"control":[137],"Results:":[141],"From":[142],"October":[143],"2014":[144],"January":[146],"2016,":[147],"768":[148],"randomized;":[151],"765":[152],"treated":[154],"(nintedanib":[155,258,264],"n":[156,160],"=":[157,161,196],"384;":[158],"381).":[162],"Median":[163],"follow-up":[164],"was":[165,172,199,284,297],"13.4":[166],"months":[167,178,183],"(interquartile":[168],"range":[169],"11.1-15.7).":[170],"OS":[171,176,282],"not":[173,280],"improved":[174],"[median":[175],"6.4":[177],"versus":[181,209,214,294],"6.0":[182],"placebo;":[185],"hazard":[186],"ratio":[187],"(HR),":[188],"1.01;":[189],"95%":[190,220],"confidence":[191],"interval":[192],"(CI),":[193],"0.86-1.19;":[194],"P":[195,223],"0.8659].":[197],"There":[198,226],"significant":[201,288],"but":[202,289],"modest":[203,290],"increase":[204,291],"PFS":[206,212,293],"(median":[211],"1.5":[213],"1.4":[215],"months,":[216],"respectively;":[217],"HR":[218],"0.58;":[219],"CI":[221],"0.49-0.69;":[222],"<":[224],"0.0001).":[225],"no":[228],"complete":[229],"partial":[231],"responses.":[232],"Adverse":[233],"events":[234],"(AEs)":[235],"occurred":[236],"97%":[238],"384":[240],"nintedanib-treated":[241],"93%":[244],"381":[246],"placebo-treated":[247],"patients.":[248],"The":[249,269],"most":[250],"frequent":[251],"grade":[252],"\u22653":[253],"AEs":[254,257],"liver-related":[256],"16%;":[259],"8%)":[261],"fatigue":[263],"9%;":[265],"6%).":[267],"Conclusions:":[268],"failed":[271],"meet":[273],"both":[274],"co-primary":[275],"points.":[277],"Nintedanib":[278,296],"did":[279],"improve":[281],"associated":[285],"placebo.":[295],"well":[298],"tolerated.":[299],"ClinicalTrials.gov":[300],"number:":[301],"NCT02149108":[302],"(LUME-Colon":[303],"1).":[304]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2884696648","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":12},{"year":2023,"cited_by_count":9},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":15},{"year":2020,"cited_by_count":11},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2018-08-03T00:00:00"}
